By Dr Ananya Mandal, MD
Cancers may be classified by their primary site of origin or by their histological or tissue types.
Classification by site of origin
By primary site of origin, cancers may be of specific types like breast cancer, lung cancer, prostate cancer, liver cancer renal cell carcinoma (kidney cancer), oral cancer, brain cancer etc.
Classification by tissue types
The international standard for the classification and nomenclature of histologies is the International Classification of Diseases for Oncology, Third Edition (ICD-O-3). This classification is based on the ICD-O-3.
Based on tissue types cancers may be classified into six major categories:
This type of cancer originates from the epithelial layer of cells that form the lining of external parts of the body or the internal linings of organs within the body.
Carcinomas, malignancies of epithelial tissue, account for 80 to 90 percent of all cancer cases since epithelial tissues are most abundantly found in the body from being present in the skin to the covering and lining of organs and internal passageways, such as the gastrointestinal tract.
Carcinomas usually affect organs or glands capable of secretion including breast, lungs, bladder, colon and prostate.
Carcinomas are of two types – adenocarcinoma and squamous cell carcinoma. Adenocarcinoma develops in an organ or gland and squamous cell carcinoma originates in squamous epithelium. Adenocarcinomas may affect mucus membranes and are first seen as a thickened plaque-like white mucosa. These are rapidly spreading cancers.
These cancers originate in connective and supportive tissues including muscles, bones, cartilage and fat. Bone cancer is one of the sarcomas termed osteosarcoma. It affects the young most commonly. Sarcomas appear like the tissue in which they grow.
Other examples include chondrosarcoma (of the cartilage), leiomyosarcoma (smooth muscles), rhabdomyosarcoma (skeletal muscles), Mesothelial sarcoma or mesothelioma (membranous lining of body cavities), Fibrosarcoma (fibrous tissue), Angiosarcoma or hemangioendothelioma (blood vessels), Liposarcoma (adipose or fatty tissue), Glioma or astrocytoma (neurogenic connective tissue found in the brain), Myxosarcoma (primitive embryonic connective tissue) and Mesenchymous or mixed mesodermal tumor (mixed connective tissue types).
These originate in the plasma cells of bone marrow. Plasma cells are capable of producing various antibodies in response to infections. Myeloma is a type of blood cancer.
This a group of cancers that are grouped within blood cancers. These cancers affect the bone marrow which is the site for blood cell production. When cancerous, the bone marrow begins to produce excessive immature white blood cells that fail to perform their usual actions and the patient is often prone to infection.
Types of leukemia include:
Acute myelocytic leukemia (AML) – these are malignancy of the myeloid and granulocytic white blood cell series seen in childhood.
Chronic myelocytic leukemia (CML) – this is seen in adulthood.
Acute Lymphatic, lymphocytic, or lymphoblastic leukemia (ALL) – these are malignancy of the lymphoid and lymphocytic blood cell series seen in childhood and young adults.
Chronic Lymphatic, lymphocytic, or lymphoblastic leukemia (CLL) – this is seen in the elderly.
Polycythemia vera or erythremia – this is cancer of various blood cell products with a predominance of red blood cells.
These are cancers of the lymphatic system. Unlike the leukemias, which affect the blood and are called “liquid cancers”, lymphomas are “solid cancers”. These may affect lymph nodes at specific sites like stomach, brain, intestines etc. These lymphomas are referred to as extranodal lymphomas.
Lymphomas may be of two types – Hodgkin’s lymphoma and Non-Hodgkin’s lymphomas. In Hodgkin lymphoma there is characteristic presence of Reed-Sternberg cells in the tissue samples which are not present in Non-Hodgkin lymphoma.
6. Mixed types
These have two or more components of the cancer. Some of the examples include mixed mesodermal tumor, carcinosarcoma, adenosquamous carcinoma and teratocarcinoma. Blastomas are another type that involves embryonic tissues.
Classification by grade
Cancers can also be classified according to grade. The abnormality of the cells with respect to surrounding normal tissues determines the grade of the cancer. Increasing abnormality increases the grade, from 1–4.
Cells that are well differentiated closely resemble normal specialized cells and belong to low grade tumors. Cells that are undifferentiated are highly abnormal with respect to surrounding tissues. These are high grade tumors.
Grade 1 – well differentiated cells with slight abnormality
Grade 2 – cells are moderately differentiated and slightly more abnormal
Grade 3 – cells are poorly differentiated and very abnormal
Grade 4 – cells are immature and primitive and undifferentiated
Classification by stage
Cancers are also classified individually according to their stage. There are several types of staging methods. The most commonly used method uses classification in terms of tumor size (T), the degree of regional spread or node involvement (N), and distant metastasis (M). This is called the TNM staging.
For example, T0 signifies no evidence of tumor, T 1 to 4 signifies increasing tumor size and involvement and Tis signifies carcinoma in situ or limited to surface cells. Similarly N0 signifies no nodal involvement and N 1 to 4 signifies increasing degrees of lymph node involvement. Nx signifies that node involvement cannot be assessed. Metastasis is further classified into two – M0 signifies no evidence of distant spread while M1 signifies evidence of distant spread.
Stages may be divided according to the TNM staging classification. Stage 0 indicates cancer being in situ or limited to surface cells while stage I indicates cancer being limited to the tissue of origin. Stage II indicates limited local spread, Stage II indicates extensive local and regional spread while stage IV is advanced cancer with distant spread and metastasis.
Reviewed by April Cashin-Garbutt, BA Hons (Cantab)
Last Updated: Dec 10, 2012